期刊文献+

血管内皮生长因子和促血管生成素及其受体Tie2在肝细胞癌发生发展中的作用 被引量:10

Significance of angiopoietins,Tie2 and VEGF expression in the carcinogenesis and development of hepatocellular carcinoma
原文传递
导出
摘要 目的探讨血管内皮生长因子(VEGF)和促血管生成素(Angiopietin)及其受体Tie2在启动肝细胞癌(HCC)血管生成中的调控机制及在HCC发生发展中的作用。方法新鲜HCC标本及癌旁肝组织38例,用实时定量逆转录-聚合酶链反应(RT-PCR)的方法检测Ang-1、Ang-2、Tie2和VEGF在各组织标本中的表达,以CD34标记新生血管内皮并计数微血管密度(MVD),分析上述因子在HCC组织和非癌肝组织中的表达差异、相互作用及其与MVD、临床病理特征之间的关系。结果Ang-1、Tie2在HCC和非癌肝组织中的表达差异无统计学意义(0.194 7±0.086 2比0.232 6±0.109 8,1.601 6±0.900 7比1.340 0±0.703 7,P均>0.05),而VEGF和Ang-2在HCC组织的表达高于非癌肝组织(1.038 0±0.572 0比0.832 3±0.182 4,0.621 3±0.417 6比0.442 9±0.330 1,P均<0.05);VEGF、Ang-2、Ang-2/1都与MVD和临床病理特征相关(P<0.01),但与组织分化程度无关(P>0.05)。结论Ang-2/1的失衡表达及其与VEGF和Tie2的共同作用是启动肝组织血管生成并诱发HCC发生、发展的重要因素;这种因素在HCC中的持续作用进一步促进了肿瘤血管生成和恶性生物学行为。 Objective To investigate the significanee of angiopoietins,Tie2 and VEGF expression in the eareinogenesis and development of hepatoeellular careinoma (HCC). Methods Fresh surgically reseeted specimens of HCC and noncancerous liver (NCL) tissues from 38 patients with HCC were obtained ,and the expression of angiopoietin-1 (Ang-1), angiopoietin-2 ( Ang-2 ), Tie2 and VEGF mRNA was examined by real-time quantitative reverse transeription-polyrnerase chain reaction (RT-PCR). Expression pattern of each gene in HCC and NCL tissues was compared and their relationship with elinieopathological parameters and mierovessel density (MVD) was also investigated. Results The expression level of Ang-2 and VEGF mRNA in HCC was significantly higher than in NCL tissues (P〈 0.05), but that of Ang-1 and Tie2 mRNA had no statistically significant difference (P 〉0.05) ,though slightly lower level of Ang-1 in HCC was observed. Ang-2/Ang-1 ratio and VEGF were both positively correlated to MVD,and the Ang-2/1 ,Ang-2 and VEGF were all associated to tumor' s elinieopathological parameters (P〈0.05) excluding histological grades (P〉0.05).Conclusion Dominant Ang-2 expression against Ang-1 through Tie2 receptor in the presence of VEGF may play critical role in initiating early neovaseularization of HCC. Its consequently constant operation induced further angiogenesis and progression of HCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第12期1492-1494,共3页 Chinese Journal of Experimental Surgery
关键词 肝细胞 血管生成 血管内皮生长因子 促血管生成素 Carcinoma, hepatocellular Angiogenesis Vascular endothelial growth factor Angiopoietin
  • 相关文献

参考文献7

  • 1李晓,王琳,郭永章,李立,张小文,崔江云,朱红.血管生成抑制素基因对裸鼠人肝癌移植瘤的治疗作用[J].中华实验外科杂志,2004,21(7):875-875. 被引量:3
  • 2张中林,刘志苏,孙权.反应停对人肝细胞癌生长侵袭的作用[J].中华实验外科杂志,2005,22(8):933-935. 被引量:8
  • 3Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin- 1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 1996, 87:1171-1807. 被引量:1
  • 4Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 1997,277:55-60. 被引量:1
  • 5Vajkoczy P, Farhadi M, Gaumann A, et al. Mierotumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest,2002,109 : 777-785. 被引量:1
  • 6Wong MP, Chan SY, Fu KH, et al. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas. Lung Cancer,2000,29: 11-22. 被引量:1
  • 7Holash J, Wiegand SJ, Yaneopoulos GD. New model of tumor angiogenesis:dynamie balance between vessel regression and growth mediated by angiopoietins and VEGF. Oneogene, 1999,18:5356-5362. 被引量:1

二级参考文献7

  • 1Li Y, Tang Y, Ye L, et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastisis-related genes through cDNA microarray- J Cancer Res Clin Oncol, 2003, 129:43-51. 被引量:1
  • 2Myoung H, Hong SD, Kim YY, et al. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma. Cancer Lett, 2001, 163 : 191-200. 被引量:1
  • 3Kotoh T, Dhar DK, Masunaga R, et al. Therapy of human esophageal cancers with thalidomide in nude mice. Surg, 1999 ; 125 : 536-544. 被引量:1
  • 4WadmanM.Cancer’cure’articlestirsuphotdebate[].Nature.1998 被引量:1
  • 5O’’ReillyMS,HolmgrenL,ShingY ,etal.Angiostatin:anovelangiogenesisinhibitorthatmediatesthesuppressionofmetastasesbyaLewislungcarcinoma[seecomments][].Cell.1994 被引量:1
  • 6Kirsch M,Strasser J,Allende R,et al.Angiostatin suppresses malignant glioma growth in vivo[].Cancer Research.1998 被引量:1
  • 7李雁,汤钊猷,叶胜龙,薛琼,陈洁,刘银坤,钦伦秀,田波.细胞角质蛋白19与肝癌模型生长转移关系的探讨[J].中华实验外科杂志,2003,20(10):903-904. 被引量:6

共引文献9

同被引文献41

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部